This disturbance appears in patients with ESRD and is characterized by extremely high levels of PTH, as well as hypercalcemia, hyperphosphatemia, and elevated levels of osteolysis and osteogenesis indicators [221,222]. This evidence concerns the gene PTH and hyperphosphatemia.